-
Medicines, lifestyle changes help in managing narcolepsy
31 Jan 2025 16:33 GMT
… alert and focused.
NARCOLEPSY is an incurable chronic … Another possible symptom of narcolepsy is sleep paralysis. During … sleep symptoms associated with narcolepsy include obstructive sleep apnoea, … have a medical condition.
Narcolepsy can also affect intimate …
-
Axsome secures hard-fought FDA nod for rapid-acting migraine drug Symbravo
31 Jan 2025 16:19 GMT
… disease and AXS-12 for narcolepsy—that have shown enough potential …
-
Cognitive Behavioral Therapy-Insomnia Demonstrates Effectiveness in Improving Cancer-Related Fatigue
31 Jan 2025 11:55 GMT
… of Sodium Oxybate in Managing Narcolepsy Symptoms
"The previously published …
-
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
31 Jan 2025 12:00 GMT
… excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea and …
-
Why I am Catholic — Sarah Charlebois
30 Jan 2025 21:29 GMT
… years, was later diagnosed with narcolepsy, and had a car accident … into “please deliver me from narcolepsy.” I was not delivered from … narcolepsy but over time my health …
-
Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
30 Jan 2025 20:45 GMT
… excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea and …
-
Takeda CEO to step down after 10 years in the driving seat
30 Jan 2025 12:59 GMT
… high hopes for its experimental narcolepsy treatment TAK-861 and a …
-
Takeda CEO succession confirmed as Weber plans retirement
30 Jan 2025 11:22 GMT
… -term pipeline includes oveporexton for narcolepsy, zasocitinib for psoriasis, and polycythemia …
-
From Night to Light: A Bibliometric Analysis of the Global Research Trajectory of Sleep Disorders in Parkinson’s Disease
30 Jan 2025 07:20 GMT
… attacks, dopamine transporters, subthalamic nucleus, narcolepsy, placebo-controlled trial, early marker …
-
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
30 Jan 2025 06:45 GMT
… -861) for the treatment of narcolepsy type 1,
zasocitinib for the …